Pfizer Begins Clinical Trial For Omicron-Targeting Vaccine

Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant.

No Responses to “Pfizer Begins Clinical Trial For Omicron-Targeting Vaccine”

Post a Comment